학술논문

Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors
Document Type
Article
Source
In ESMO Open August 2022 7(4)
Subject
Phase I Trials
Language
ISSN
2059-7029